LS
Lisa Schechner
Investor at Commodore Capital
New York, New York
Overview
Lisa Schechner is a Biotechnology Investor at Commodore Capital, LP in New York City, with a background in management consulting and business strategy. She has held various roles at Roivant Sciences, including Director of Business Operations, and has experience in financial modeling and market research.
Lisa's career highlights include her current role as a Biotechnology Investor at Commodore Capital, LP, where she focuses on investing in Series A and Seed stage companies in the Pharmaceuticals and Biotech sectors, and her previous positions at Roivant Sciences, where she progressed from Senior Analyst to Director of Business Operations.
Work Experience
Biotechnology Investor
2021 - Current
Senior Associate, Investments
2021 - 2021
Associate, Investments
2020 - 2021
Senior Analyst, Investments
2017 - 2020
Director, Business Operations
2015 - 2017
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Raised $2,473,000,000.00 from Eventide, Fidelity, Viking Global Investors, RTW Investments, Patient Square Capital, Palantir Technologies, Dainippon Sumitomo Pharma, Suvretta Capital Management and SoftBank Capital.
Consultant
2014 - 2015
Senior Associate Consultant
2013 - 2014
Associate Consultant
2011 - 2013